Christina Lake CannabisCLCFF -11.49% EBITDA Margin % is 41.11% as of Nov. 2025. The stock has 5 warning signs investors should review. Among 955 Drug Manufacturers companies, Christina Lake Cannabis ranks better than 97.8% on this metric.
Christina Lake Cannabis (OTCPK:CLCFF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Christina Lake Cannabis EBITDA Margin % Related Terms
Christina Lake Cannabis EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Christina Lake Cannabis's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Christina Lake Cannabis EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Christina Lake Cannabis's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Christina Lake Cannabis's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Christina Lake Cannabis (CLCFF) has a EBITDA Margin % of 41.11% as of Nov. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Christina Lake Cannabis and its competitors. According to the industry distribution chart, Christina Lake Cannabis ranks #21 out of 955 companies in the Drug Manufacturers industry, placing it in the top 2.2%.
Is Christina Lake Cannabis' EBITDA Margin % too high?
Christina Lake Cannabis' current EBITDA Margin % is 41.11%. The Drug Manufacturers industry median EBITDA Margin % is 12.44. Christina Lake Cannabis' value of 41.11% is 230.5% above this industry median. Based on the distribution chart, Christina Lake Cannabis ranks #21 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Christina Lake Cannabis' EBITDA Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Christina Lake Cannabis ranks #21 out of 955 companies for EBITDA Margin %. This places Christina Lake Cannabis in the top 2% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 12.44. Christina Lake Cannabis' value of 41.11% is 230.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Christina Lake Cannabis's current EBITDA Margin % of 41.11% is 230.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Christina Lake Cannabis and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Christina Lake Cannabis's current EBITDA Margin % is 41.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Christina Lake Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Christina Lake Cannabis (CLCFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.04, compared to a current price of $0.02 — trading 53% below its estimated fair value. The current EBITDA Margin % is 41.11% and 230.5% above the Drug Manufacturers industry median of 12.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Christina Lake Cannabis (CLCFF), the current EBITDA Margin % is 41.11% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Christina Lake Cannabis Corp is a licensed producer of cannabis. The company cultivates cannabis using strains specifically developed for outdoor cultivation. It is a producer of high-quality, low-cost, sun-grown cannabis flowers, oil cannabinoids, and hemp-based extracts and derivatives, serving domestic and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCFF has been successfully added to your 